Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Autoimmune Diseases

NCT07072884 is registered in ClinicalTrials.gov with Qiong Fu as lead sponsor.

NCT NCT07072884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07072884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Autoimmune Diseases
Lead sponsor
Qiong Fu
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 18, 2025
Completion date
March 31, 2029
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic inflammatory myopathy (iim), systemic sclerosis (ssc)